Goldman Sachs’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-26,400
| Closed | -$4.75M | – | 6948 |
|
|
2017
Q3 | $4.75M | Sell |
26,400
-9,300
| -26% | -$1.3M | ﹤0.01% | 3197 |
|
|
2017
Q2 | $3.7M | Buy |
35,700
+9,900
| +38% | +$808K | ﹤0.01% | 3313 |
|
|
2017
Q1 | $2.02M | Buy |
25,800
+4,200
| +19% | +$260K | ﹤0.01% | 3734 |
|
|
2016
Q4 | $969K | Sell |
21,600
-138,700
| -87% | -$6.8M | ﹤0.01% | 4482 |
|
|
2016
Q3 | $8.95M | Buy |
160,300
+135,100
| +536% | +$7.53M | ﹤0.01% | 2547 |
|
|
2016
Q2 | $1.26M | Sell |
25,200
-21,900
| -46% | -$1.08M | ﹤0.01% | 4000 |
|
|
2016
Q1 | $2.16M | Sell |
47,100
-1,000
| -2% | -$48.4K | ﹤0.01% | 3401 |
|
|
2015
Q4 | $2.96M | Sell |
48,100
-18,600
| -28% | -$1.31M | ﹤0.01% | 3292 |
|
|
2015
Q3 | $3.71M | Buy |
66,700
+33,200
| +99% | +$2.09M | ﹤0.01% | 3161 |
|
|
2015
Q2 | $2.04M | Buy |
33,500
+3,600
| +12% | +$205K | ﹤0.01% | 3808 |
|
|
2015
Q1 | $1.73M | Buy |
+29,900
| New | +$2M | ﹤0.01% | 3938 |
|
Goldman Sachs's KITE Position: Q4 2017 in Review
Goldman Sachs sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 806,480 shares — an estimated $145M sold.
Goldman Sachs first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $145M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Goldman Sachs reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Goldman Sachs sold 806,480 Kite Pharma, Inc. shares in Q4 2017, an estimated $145M.
- Goldman Sachs first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
- Goldman Sachs's Kite Pharma, Inc. position peaked at $145M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.